228 Afleveringen

  1. John Mascarenhas, MD - Working With Our Patients as Partners in Care: Addressing Disease- and Treatment-Related Burdens Associated With Cytopenic Myelofibrosis

    Gepubliceerd: 21-11-2024
  2. Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow

    Gepubliceerd: 21-11-2024
  3. Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps

    Gepubliceerd: 15-11-2024
  4. Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care

    Gepubliceerd: 15-11-2024
  5. Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML

    Gepubliceerd: 15-11-2024
  6. Richard Kim, MD - The Modern Art of Sequencing Later Lines of Treatment for Advanced Colorectal Cancer: Exploring Case Scenarios With the Experts

    Gepubliceerd: 8-11-2024
  7. Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED

    Gepubliceerd: 8-11-2024
  8. Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

    Gepubliceerd: 8-11-2024
  9. Carla M. Nester, MD, MSA, FASN - Novel Therapies in Focus: Updates in C3 Glomerulopathy and IC-MPGN

    Gepubliceerd: 8-11-2024
  10. Bruce A C Cree, MD, PhD, MAS - BTK Inhibition & Beyond: Novel Therapies in MS

    Gepubliceerd: 25-10-2024
  11. Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey

    Gepubliceerd: 25-10-2024
  12. Elena Castro, MD, PhD - Innovation and Individualisation in mHSPC and nmCRPC: Optimising Patient Outcomes and Experiences

    Gepubliceerd: 25-10-2024
  13. Karin Jordan, MD, PhD - Applying Foresight to Optimise Emesis Control in Patients Receiving Antibody-Drug Conjugates

    Gepubliceerd: 25-10-2024
  14. Karin Jordan, MD, PhD - Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting

    Gepubliceerd: 11-10-2024
  15. Peter Schmid, FRCP, MD, PhD - Staying at the Forefront of HER2 and TROP2-Directed Antibody-Drug Conjugate Advances in Breast Cancer

    Gepubliceerd: 11-10-2024
  16. Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening

    Gepubliceerd: 30-9-2024
  17. Jiwon Oh, MD, PhD, FRCPC - Navigating the High-Efficacy DMT Landscape in MS: Integrating New Data and Real-World Evidence

    Gepubliceerd: 30-9-2024
  18. Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey

    Gepubliceerd: 30-9-2024
  19. Pamela Kushner, MD, FAAFP / Magdalena Madero, MD - Taking the Updated CKD Guidelines From Paper to Practice

    Gepubliceerd: 12-9-2024
  20. Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?

    Gepubliceerd: 27-8-2024

2 / 12

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Visit the podcast's native language site